LAVAL, QUEBEC–(Marketwired – Aug. 4, 2015) – ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), (“ProMetic” or the “Corporation”) announced today that an orphan drug designation status has been granted for its human […]
Scientists who mapped the DNA of the New York City subway system have backed off a claim that they discovered traces of anthrax and bubonic plague at several stations, after […]
PITTSBURGH–(BUSINESS WIRE)–ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, today announced the publication of new data by […]
NEW YORK & CHICAGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the establishment of the Immuno-Oncology Rare Population Malignancy (I-O RPM) program in the U.S. The I-O RPM program is a […]
Pfizer Inc. and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, today announced they have entered into an agreement whereby Pfizer has acquired the exclusive […]
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen’s Partner, Lexicon Pharmaceuticals, Announces Positive Results from TELESTAR Phase 3 Study Showing That Telotristat Etiprate is Effective in the Treatment of Carcinoid Syndrome Caused by Neuroendocrine […]
As hospital operators begin to report second period earnings — the sixth consecutive quarter of new revenue from once uninsured patients — the number and size of unpaid medical bills […]
